LOL - just ensuring everyone sees this sarcasm and does not really believe it, there is always one numbskull that does not think with their brain when readingJD added so much value though - changed the Pharm name to "innovative medicine" - complete game changer!
LOL exactly - love how our leaders have to clarify what the fuck innovative medicine is when being interviewed by the media....b/c no one knows what the fuck it even means. Complete morons at the top.LOL - just ensuring everyone sees this sarcasm and does not really believe it, there is always one numbskull that does not think with their brain when reading
YesSerious Question…Does JD realize he is solely running a $100BB into the ground? WHILE he is putting $15-16MM into his own bank account.
He does not care! They (J&J execs) don't care! The Credo doesn't not matter. IT'S ALL BS! IT'S ALL ABOUT THE CASH FLOW. There is no accountability other than to shareholders. As long as they can spin disasters like Abiomed to the shareholders, IT DOESN'T MATTER.Serious Question…Does JD realize he is solely running a $100BB into the ground? WHILE he is putting $15-16MM into his own bank account.
reeds a pinhead and clueless about drug discovery. he did nothing at roche or sanofi. hasnt done anything at jj except downsizeOur that John Reed... From now of on we will have one NME a year going to the market. Well John, I've got an even better idea.. let's make it two.
And don't forget about logo change to Arial font. JD delivers!JD added so much value though - changed the Pharm name to "innovative medicine" - complete game changer!
The name changes are necessary as they set the stage to separate MedTech and Innovation Medicine in the future, similar to BD.And don't forget about logo change to Arial font. JD delivers!
Dumb Management Shits fell for it. And yes, kids can sign their name in cursive.The name changes are necessary as they set the stage to separate MedTech and Innovation Medicine in the future, similar to BD.
The font change was a money grab for branding consultants and potential kickbacks.
He was the sole reason for his previous company being driven into the ground. Why did we hunt out this external failure when we have pretty decent talent internallyreeds a pinhead and clueless about drug discovery. he did nothing at roche or sanofi. hasnt done anything at jj except downsize
Friend of yours?What Ajay has to do with the post?